Literature DB >> 9096420

Extraintestinal pathology associated with Helicobacter infection.

A Gasbarrini, F Franceschi, G Gasbarrini, P Pola.   

Abstract

Helicobacter pylori appears to be the most important cause of gastritis and gastric and duodenal ulcer. Its eradication, in fact, promotes healing of these diseases and significantly reduces ulcer recurrence. In the last few years, moreover, besides a local tissue damage, an association between H. pylori infection and various extraintestinal pathologies has also been described. The presence of more toxic strains of H. pylori and the multiplicity of the substances produced, directly or indirectly, in response to the bacterium, besides a genetic predisposition of the individual, are all factors which may enhance the ability of Helicobacter to generate both local and systemic damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096420     DOI: 10.1097/00042737-199703000-00001

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

1.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias.

Authors:  Francesco Franceschi; Donatella Brisinda; Francesco Buccelletti; Maria Pia Ruggieri; Antonio Gasbarrini; Annarita Sorbo; Davide Marsiliani; Angela Venuti; Peter Fenici; Giovanni Gasbarrini; Nicolò Gentiloni Silveri; Riccardo Fenici
Journal:  Intern Emerg Med       Date:  2011-05-12       Impact factor: 3.397

3.  Association between Helicobacter pylori infection and adult height.

Authors:  Paul Moayyedi; David Forman; Sara Duffett; Su Mason; Julia Brown; Will Crocombe; Richard Feltbower; Anthony Axon
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  No evidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis.

Authors:  C Di Campli; R Nocente; G Costamagna; N Gentiloni; R Burioni; J Wu; A Armuzzi; M A Zern; G Gasbarrini; A Gasbarrini
Journal:  Int J Pancreatol       Date:  2000-12

5.  Helicobacter pylori seroconversion in asymptomatic blood donors: a five-year follow-up.

Authors:  M Menegatti; N Figura; S Farinelli; F Landi; C Acciardi; C Ricci; J Holton; L Gatta; M Crosatti; R Polacci; M Miglioli; D Vaira
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

6.  Modalities of testing Helicobacter pylori in patients with nonmalignant bile duct diseases.

Authors:  Milutin Bulajic; Bojan Stimec; Miroslav Milicevic; Matthias Loehr; Petra Mueller; Ivan Boricic; Nada Kovacevic; Mirko Bulajic
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.

Authors:  A Gasbarrini; I Massari; M Serricchio; P Tondi; A De Luca; F Franceschi; V Ojetti; A Dal Lago; R Flore; A Santoliquido; G Gasbarrini; P Pola
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 8.  Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection.

Authors:  Francesco Franceschi; Robert M Genta; Antonio R Sepulveda
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

9.  Acquired angioedema and Helicobacter pylori infection in a child.

Authors:  Jana Varvarovska; Josef Sykora; Frantisek Stozicky; Ivan Chytra
Journal:  Eur J Pediatr       Date:  2003-08-01       Impact factor: 3.183

10.  Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria.

Authors:  C Di Campli; A Gasbarrini; E Nucera; F Franceschi; V Ojetti; E Sanz Torre; D Schiavino; P Pola; G Patriarca; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.